Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:905-907, doi:10.1016/j.jacc.2008.06.015
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Rourke, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O'Rourke, R. A.

CLINICAL RESEARCH: INTERVENTIONAL CARDIOLOGY

Optimal Medical Therapy Is a Proven Option for Chronic Stable Angina

Robert A. O'Rourke, MD, MACP, MACC, FAHA*

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Manuscript received May 23, 2008; accepted June 2, 2008.

* Reprint requests and correspondence: Dr. Robert A. O'Rourke, 116 Village Circle, San Antonio, Texas 78232 (Email: RAOROURKE{at}aol.com).

The authors of the meta-analysis of a percutaneous coronary intervention (PCI)-based invasive strategy for improving prognosis for the treatment of angina conclude that a pooling of data from various studies can be sufficiently powered to evaluate the impact of PCI on long-term mortality. However, most randomized coronary artery patient trials have insufficient power to detect significant differences in hard end points. Randomized trials in patients with chronic stable angina enroll few patients who are over age 65 years, have depressed ventricular function, have clinical instability, or who have undergone previous coronary artery bypass grafting (CABG) or PCI. "Medical therapy" today no longer means the absence of PCI, but rather the presence of intensive, evidence-based pharmacologic intervention. The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial randomized 2,287 patients to optimal medical therapy alone or optimal medical therapy plus PCI. Optimal medical therapy consisted of antiplatelet therapy, anti-ischemic therapy, and aggressive lipid and blood pressure control. Based on the strength of the evidence, the author of this commentary recommends more-aggressive medical therapy for patients with moderate-to-severe angina, and PCI or CABG for many patients in whom symptoms persist. Optimal medical therapy is a proven option for chronic stable angina.

Key Words: chronic stable angina • PCI • long-term follow-up • anti-anginal therapy • hard cardiovascular end points

Abbreviations and Acronyms
  CABG = coronary artery bypass grafting
  PCI = percutaneous coronary intervention




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. Arbab-Zadeh
Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
J. Am. Coll. Cardiol., February 10, 2009; 53(6): 528 - 529.
[Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Meta-Analysis of Percutaneous Coronary Intervention in Stable Angina -- A Contrast with COURAGE
Journal Watch Cardiology, October 8, 2008; 2008(1008): 3 - 3.
[Full Text]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement